JSAM
PCVX icon

J. Safra Asset Management’s Vaxcyte PCVX Stock Holding History

J. Safra Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$630K Buy
10,850
+3,796
+54% +$206K 0.03% 145
2025
Q4 		$325K Buy
7,054
+1,070
+18% +$47.9K 0.02% 185
2025
Q3 		$216K Buy
5,984
+1,912
+47% +$63.3K 0.01% 166
2025
Q2 		$132K Buy
4,072
+669
+20% +$21.9K 0.01% 174
2025
Q1 		$128K Buy
3,403
+1,496
+78% +$120K 0.01% 158
2024
Q4 		$156K Buy
1,907
+736
+63% +$73.1K 0.01% 141
2024
Q3 		$132K Buy
1,171
+564
+93% +$50.8K 0.01% 101
2024
Q2 		$45.8K Buy
607
+526
+649% +$35.8K ﹤0.01% 147
2024
Q1 		$5.53K Buy
+81
New +$5.61K ﹤0.01% 153

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return